FDA approves Geneoscopy's ColoSense test for CRC screening [Yahoo! Finance]
Laboratory Corporation of America Holdings (LH)
Last laboratory corporation of america holdings earnings: 4/29 06:53 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=84636&p=irol-irhome
Company Research
Source: Yahoo! Finance
The ColoSense test is designed to detect colorectal neoplasia-associated RNA markers and occult haemoglobin in human stool. The test, which is to be used with the ColoSense Collection Kit, Test Kit and Software, as well as specific instruments, is performed at a single site at Geneoscopy. ColoSense has been designated as a breakthrough device by the FDA and is said to be the first to utilise RNA biomarkers for a dynamic view of disease activity. The CRC-PREVENT trial, which included participants from diverse backgrounds, showed that ColoSense had a 93% sensitivity for CRC detection and a 45% sensitivity for advanced adenomas (AA) detection in average-risk individuals. Furthermore, the trial highlighted a 100% sensitivity rate for CRC in the age group of 45-49 years, which is significant for early-age onset CRC prevention. Geneoscopy CEO and co-founder Andrew Barnell said: “Securing FDA approval for ColoSense marks a significant milestone for Geneoscopy and demonstrates that
Show less
Read more
Impact Snapshot
Event Time:
LH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LH alerts
High impacting Laboratory Corporation of America Holdings news events
Weekly update
A roundup of the hottest topics
LH
News
- Labcorp (LH) to Assess Preeclampsia Risk With New Test [Yahoo! Finance]Yahoo! Finance
- Drug Screening Market Worth $19.5 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Labcorp launches first trimester preeclampsia screening test [Yahoo! Finance]Yahoo! Finance
- New screening tool can identify preeclampsia risk sooner, test maker says [CNN]CNN
- Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy [Yahoo! Finance]Yahoo! Finance
LH
Earnings
- 4/25/24 - Beat
LH
Sec Filings
- 5/17/24 - Form S-8
- 5/17/24 - Form S-3ASR
- 5/17/24 - Form POSASR
- LH's page on the SEC website